What are the latest treatments for hepatitis C?

I believe that many people are confused about hepatitis C. In fact, the occurrence of this disease poses a serious threat to the patient's health. Therefore, it is necessary to understand the correct and effective treatment methods, use some antiviral drugs scientifically, and eat a reasonable and healthy diet and supplement vitamins.

1. Deficiency of vital energy and toxic stasis

Chronic hepatitis C is a disease of both deficiency of the root and excess of the superficial symptoms, with heat toxins and blood stasis toxins being the main symptoms. Because the evil toxins are abundant inside the body, they directly enter the blood, where they stagnate and damage the vital energy. The vital energy is weak, and it is difficult to expel the evil toxins. The two are mutually causal, making the disease lingering and difficult to cure, or even worsening and turning into a symptom accumulation. Liver depression and spleen deficiency: Evil toxins are deeply hidden in the blood and remain in the liver, causing liver qi stagnation, abnormal qi secretion, and spleen dysfunction, or damp heat evil is absorbed from the outside, affecting spleen function, blocking qi movement, fumigating the liver and gallbladder, and causing heat and toxin stagnation and liver and spleen damage.

2. Acute hepatitis

It is generally self-limited and most people recover completely. General treatment and symptomatic supportive treatment are the mainstay. Isolation is required during the acute phase, and those with obvious symptoms and jaundice should rest in bed. The amount of activity can be gradually increased during the recovery phase, but overwork should be avoided. You can return to work 1-3 months after your liver function returns to normal. Give light and easily digestible food, appropriate vitamin supplements, and strive to achieve protein intake of 1-1.5g/kg per day. Those with insufficient calories should receive intravenous glucose supplements. Assisted by symptomatic medication and restoration of liver coldness, not too much medication should be used to avoid increasing the burden on the liver. Antiviral treatment is generally not used, but acute hepatitis C is an exception. Because acute hepatitis C can easily turn into chronic hepatitis, early use of antiviral drugs can reduce the rate of conversion. Interferon or long-acting interferon can be used, with a course of 24 weeks, and ribavirin can be added at the same time.

3. Ordinary interferon α (IFNα) combined with ribavirin

In 1992, the US FDA approved the combination of interferon α-2b and ribavirin for the treatment of acute or chronic hepatitis C, with a cure rate of 41-47%, meaning that the serum hepatitis C virus remains negative after more than five years of follow-up after achieving SVR. A direct comparative clinical trial of two long-acting interferons combined with ribavirin showed that the recurrence rate of 12KD pegylated interferon alfa-2b was significantly lower than that of 40KD pegylated interferon alfa-2a, which may be related to the antiviral activity and drug distribution caused by molecular size.